期刊文献+

血浆D-二聚体测定在食管癌诊治中的价值 被引量:2

The Value of D-Dimer in the Diagnosis and Treatment of Esophageal Cancer
下载PDF
导出
摘要 目的:探讨血浆D-二聚体水平在食管癌患者诊治中的临床价值。方法:测定120例食管癌患者血浆D-二聚体水平,并与健康对照组进行比较,分析食管癌患者术前D-二聚体水平与临床病理特征的关系及手术前后D-二聚体水平变化。结果:食管癌组术前血浆D-二聚体水平显著高于健康对照组,并随TNM分期的进展而升高,有并发症者术前D二聚体水平显著高于无并发症组,术后2周D-二聚体水平显著低于术前,Ⅲ~Ⅳ期患者下降更为显著,有并发症组术后2周D-二聚体水平仍显著高于健康对照组(P〈0.05)。结论:D-二聚体检测方法灵敏度高,可作为食管癌患者辅助诊断、治疗及手术风险评价的指标。 Objective: To explore the value of D-Dimer level in the diagnosis and treatment for patients with esophageal carcinoma. Method: The level of D-Dimer of 120 eases of patients with esophageal carcinoma was tested before and after operation, and was compared with healthy eobert.Exploring the relationship between the level of D-Dimer and the clinical and patholagieal parameters, analyzing the variation of D-Direct before and after esophagectomy.Result: The D-Dimer level of patients with esophageal cancer was higher than that of the healthy cohort.Compared with early stage, the level of D-Dimer was higher in patients with advanced TNM stage cancer.Groups were comparable in clinical features.The increase of preoperative D-Dimer was related to postoperative combination.The D-Dimer of the most patients decreased dramatically 2 weeks after the treatment of surgery, especially in the Ⅲ-Ⅳ TNM stage cases, however the level of the patients with serious postoperative combinations was still higher than the healthy eohort(P〈0.05).Conclusion: D-Dimer is a reliable sensitive factor and is helpful for the auxiliary diagnosis and treatment.It is also a predictor of the surgical risk for the esophageal carcinoma.
作者 杨冉 韩金利
机构地区 安阳市肿瘤医院
出处 《中外医学研究》 2015年第25期63-65,共3页 CHINESE AND FOREIGN MEDICAL RESEARCH
关键词 食管癌 手术治疗 D-二聚体 Esophageal carcinoma Surgical treatment D-Dimer
  • 相关文献

参考文献10

  • 1Ferlay J, Shin H R, Bray F, et al.Estimates of worldwide burden of cancer in 2008 : GLOBOCAN 2008[J].Int J Cancer, 2010, 127(12): 2893-291,7.
  • 2Chen W, Zheng R, Zhang S, et al.Report of cancer incidence and mortality in China, 2010[J].Ann Transl Med, 2014, 2(7): 61-85.
  • 3张思维,雷正龙,李光琳,邹小农,赵平,陈万青.中国肿瘤登记地区2006年肿瘤发病和死亡资料分析[J].中国肿瘤,2010,19(6):356-365. 被引量:192
  • 4Chen G, Wang Z, Liu X Y, et al.Recurrence pattern of squamous cell carcinoma in the middle thoracic esophagus after modified Ivor- Lewis esophagectomy[J].World J Surg, 2007, 31(5): 1107-1114.
  • 5Ay C, Vormittag R, Dunkler D, et al.D-dimer and prothrombin fragment 1+2 predict venous thromboembolism in patients with cancer:results from the Vienna Cancer and Thrombosis Study[J].J Clin Oneol, 2009, 27(25): 4124-4129.
  • 6Deeousus H, Moulin N, Quenet S, et al.Thrombophilia and risk of venous thrombosis in patients with eancer[J].Thromb Res, 2007, 120 (Suppl 2): 51-61.
  • 7Komurcuoglu B, Ulusoy S, Gayaf M, et al.Prognostic value of plasma D-dimer levels in lung carcinoma[J].Tumori, 2011, 97(6) : 743-748.
  • 8Dirix L Y, Salgado R, Weytjens R, et al.Plasma fibrin D-dimer levels correlate with tumour volume, progression rate and survival inpatients with metastatic breast cancer[J].Br J Cancer, 2002, 86(3): 389-395.
  • 9Yamamoto M, Yoshinaga K, Matsuyama A, et al.Plasma D-dimer level as a mortality predictor in patients with advanced or recurrent colorectalcancer[J].Oncology, 2012, 83(1): 10-15.
  • 10Tas F, Kilic L, Bilgin E, et al.Clinical and prognostic significance of coagulation assays in advanced epithelial ovarian cancer[J].Int J GynecolCancer, 2013, 23(2): 276-281.

二级参考文献9

  • 1张思维,雷正龙,李光琳,邹小农,陈万青,赵平.中国肿瘤登记地区2005年发病死亡资料分析[J].中国肿瘤,2009,18(12):973-979. 被引量:32
  • 2Bray F, Parkin DM. Evaluation of data quality in the cancer registry: principles and methods. Part I : comparability, validity and timeliness [J]. Eur J Cancer, 2009, 45: 747-755.
  • 3Curado MP, Edwards B, Shin HR, et al. Cancer incidence in five continents, Vol. IX. IARC scientific: publications No. 160[M], Lyon: IARC, 2007.
  • 4Parkin DM, Chen VM, Ferlay J, et al. Comparability and quality control in cancer registration. IARC technical report No.19[M]. Lyon: IARC, 1994.
  • 5Felay J, Bnrkhard C, Whelan S, et al. Check and conversion programs for cancerregistries. IARC Technical Report No. 42[M]. Lyon: IARC, 2005.
  • 6Felay J. The IARCcrgTools program [EB/OL]. http://www.iacr.com.fr/iarccrgtools.htm, 2006.
  • 7赵平,陈万青.2008年中国肿瘤登记年报[M].第1版.北京:军事医学科学出版社,2009.88-89.
  • 8全国肿瘤登记中心.中国肿瘤登记工作指导手册[M].北京:中国协和医科大学出版社,2004.48-50.
  • 9陈建国.癌症登记资料的质量评价[J].中国肿瘤,1999,8(3):100-104. 被引量:38

共引文献191

同被引文献15

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部